Filed: 8/14/2025ACC: 0001104659-25-078732
📋 What this filing means
ACUTA CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 28 equity positions with a total reported market value of $71.64M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
28
Positions
$71.64M
Total AUM (reported)
7.76M
Total Shares
Allocation by class
COM$39.22M54.7%
COM NEW$13.10M18.3%
SPONSORED ADR$7.59M10.6%
COM PAR $.01$3.73M5.2%
SHS USD$2.79M3.9%
ORDINARY SHARES$2.07M2.9%
CL A ORD SHS$1.99M2.8%
Portfolio Concentration
Top 3$24.54M34.3%
4–10$27.08M37.8%
11–25$19.70M27.5%
Rest$320.6K0.4%
Top 3 weight
34.3%
Top 10 weight
72.1%
Voting Authority Distribution
Total shares with voting rights: 7.76M
Sole
Full voting authority
7.76M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole28
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings28
Rows:
OCULAR THERAPEUTIX INC
SOLEShares1.01M
TypeSH
Market value$9.42M
13.15%
Sole
1.01M
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares179.57K
TypeSH
Market value$8.75M
12.21%
Sole
179.57K
Shared
0.00
None
0.00
WHITEHAWK THERAPEUTICS INC
SOLEShares3.41M
TypeSH
Market value$6.38M
8.90%
Sole
3.41M
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares63.44K
TypeSH
Market value$5.31M
7.42%
Sole
63.44K
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares283.68K
TypeSH
Market value$4.54M
6.33%
Sole
283.68K
Shared
0.00
None
0.00
ASCENDIS PHA-ADR
SOLEShares22.58K
TypeSH
Market value$3.90M
5.44%
Sole
22.58K
Shared
0.00
None
0.00
INSMED INC
SOLEShares37.07K
TypeSH
Market value$3.73M
5.21%
Sole
37.07K
Shared
0.00
None
0.00
ARGEN SE - ADR
SOLEShares6.70K
TypeSH
Market value$3.69M
5.16%
Sole
6.70K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares74.09K
TypeSH
Market value$3.12M
4.35%
Sole
74.09K
Shared
0.00
None
0.00
JAZZ PHARMACEUTICALS PLC
SOLEShares26.28K
TypeSH
Market value$2.79M
3.89%
Sole
26.28K
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares493.74K
TypeSH
Market value$2.70M
3.77%
Sole
493.74K
Shared
0.00
None
0.00
OCULIS HOLDING AG
SOLEShares106.72K
TypeSH
Market value$2.07M
2.89%
Sole
106.72K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares55.69K
TypeSH
Market value$2.05M
2.86%
Sole
55.69K
Shared
0.00
None
0.00
HELIX ACQUISITION CORP II
SOLEShares187.26K
TypeSH
Market value$1.99M
2.78%
Sole
187.26K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares463.86K
TypeSH
Market value$1.73M
2.42%
Sole
463.86K
Shared
0.00
None
0.00
SURROZEN, INC.
SOLEShares170K
TypeSH
Market value$1.52M
2.12%
Sole
170K
Shared
0.00
None
0.00
BRIGHT MINDS BIOSCIENCES INC
SOLEShares48.47K
TypeSH
Market value$1.27M
1.77%
Sole
48.47K
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares485.67K
TypeSH
Market value$1.12M
1.57%
Sole
485.67K
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares19.77K
TypeSH
Market value$1.06M
1.47%
Sole
19.77K
Shared
0.00
None
0.00
ZYMEWORKS INC
SOLEShares83.66K
TypeSH
Market value$1.05M
1.47%
Sole
83.66K
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares75.88K
TypeSH
Market value$945.4K
1.32%
Sole
75.88K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL INC
SOLEShares23.81K
TypeSH
Market value$865.9K
1.21%
Sole
23.81K
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares150.41K
TypeSH
Market value$624.2K
0.87%
Sole
150.41K
Shared
0.00
None
0.00
FULCRUM THERAPEUTICS INC
SOLEShares59.65K
TypeSH
Market value$410.4K
0.57%
Sole
59.65K
Shared
0.00
None
0.00
UNICYCIVE THERAPEUTICS INC
SOLEShares62.90K
TypeSH
Market value$300.0K
0.42%
Sole
62.90K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
OCULAR THERAPEUTIX INCSOLE | COM | 1.01M | SH | $9.42M 13.15% | 1.01M | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COM NEW | 179.57K | SH | $8.75M 12.21% | 179.57K | 0.00 | 0.00 |
WHITEHAWK THERAPEUTICS INCSOLE | COM | 3.41M | SH | $6.38M 8.90% | 3.41M | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 63.44K | SH | $5.31M 7.42% | 63.44K | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | COM | 283.68K | SH | $4.54M 6.33% | 283.68K | 0.00 | 0.00 |
ASCENDIS PHA-ADRSOLE | SPONSORED ADR | 22.58K | SH | $3.90M 5.44% | 22.58K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 37.07K | SH | $3.73M 5.21% | 37.07K | 0.00 | 0.00 |
ARGEN SE - ADRSOLE | SPONSORED ADR | 6.70K | SH | $3.69M 5.16% | 6.70K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM | 74.09K | SH | $3.12M 4.35% | 74.09K | 0.00 | 0.00 |
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 26.28K | SH | $2.79M 3.89% | 26.28K | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 493.74K | SH | $2.70M 3.77% | 493.74K | 0.00 | 0.00 |
OCULIS HOLDING AGSOLE | ORDINARY SHARES | 106.72K | SH | $2.07M 2.89% | 106.72K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 55.69K | SH | $2.05M 2.86% | 55.69K | 0.00 | 0.00 |
HELIX ACQUISITION CORP IISOLE | CL A ORD SHS | 187.26K | SH | $1.99M 2.78% | 187.26K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 463.86K | SH | $1.73M 2.42% | 463.86K | 0.00 | 0.00 |
SURROZEN, INC.SOLE | COM NEW | 170K | SH | $1.52M 2.12% | 170K | 0.00 | 0.00 |
BRIGHT MINDS BIOSCIENCES INCSOLE | COM NEW | 48.47K | SH | $1.27M 1.77% | 48.47K | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 485.67K | SH | $1.12M 1.57% | 485.67K | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 19.77K | SH | $1.06M 1.47% | 19.77K | 0.00 | 0.00 |
ZYMEWORKS INCSOLE | COM | 83.66K | SH | $1.05M 1.47% | 83.66K | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 75.88K | SH | $945.4K 1.32% | 75.88K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INCSOLE | COM | 23.81K | SH | $865.9K 1.21% | 23.81K | 0.00 | 0.00 |
VERASTEM INCSOLE | COM NEW | 150.41K | SH | $624.2K 0.87% | 150.41K | 0.00 | 0.00 |
FULCRUM THERAPEUTICS INCSOLE | COM | 59.65K | SH | $410.4K 0.57% | 59.65K | 0.00 | 0.00 |
UNICYCIVE THERAPEUTICS INCSOLE | COM | 62.90K | SH | $300.0K 0.42% | 62.90K | 0.00 | 0.00 |
Page 1 of 2